USANA Health Sciences USNA Deferred Compensation Liability, Classified, Noncurrent

Deferred Compensation Liability, Classified, Noncurrent at other companies

Nature's Sunshine ProductsNATR

——

BalchemBCPC

——

Other financials

Income statement

See full

Revenue$250.2M+0.3%

Gross profit$190.8M-3.2%

Operating income$13.9M-11.5%

Net income$7.5M-20.1%

EPS (diluted)$0.41-16.3%

Balance sheet

See full

Cash & equivalents$165.7M-9.2%

Total debt$18.0M+10.8%

Total equity$543.6M+2.6%

Total assets$739.0M-1.0%

Cash flow

See full

Operating cash flow$9.8M-37.0%

CapEx$2.6M-5.6%

Free cash flow$7.1M-43.9%

Valuation

See full

Market cap$363.35M-36.1%

P/E18.1×+7.8×

P/S0.4×-0.3×

Profitability

See full

Gross margin77.6%-3.0pp

Operating margin3.8%-2.7pp

Net margin1.9%-4.4pp

FCF margin5.7%-1.1pp

Returns & leverage

See full

Return on equity3.2%-7.6pp

Debt / equity0×0.0×

Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's deferred compensation liability, classified, noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is USANA Health Sciences's deferred compensation liability, classified, noncurrent?: USANA Health Sciences (USNA) reported deferred compensation liability, classified, noncurrent of $5.68M in Q1 2026.